Anorexia Nervosa: Core Features, Medical Complications, and Treatment

Anorexia nervosa (AN) is a severe eating disorder characterized by restriction of energy intake relative to requirements leading to significantly low body weight, intense fear of gaining weight, and disturbance in body weight/shape perception (DSM-5).

Diagnostic Subtypes

  • Restricting type (AN-R): Weight loss via dieting, fasting, excessive exercise.
  • Binge-eating/purging type (AN-BP): Recurrent binge eating or purging (vomiting, laxatives, diuretics, enemas) in past 3 months.

Medical Complications (Systemic)

SystemComplications
CardiovascularBradycardia, hypotension, orthostasis, QT prolongation, arrhythmias, cardiomyopathy, sudden cardiac death (leading cause of mortality)
EndocrineAmenorrhea (hypogonadotropic), low estrogen/testosterone, bone loss (osteopenia/osteoporosis), sick euthyroid syndrome, growth retardation
GastrointestinalGastroparesis, constipation, hepatomegaly (fatty infiltration), pancreatitis (refeeding), superior mesenteric artery syndrome
Renal/ElectrolyteHypokalemia, hyponatremia, hypophosphatemia, metabolic alkalosis (vomiting), renal impairment
HematologicAnemia, leukopenia, thrombocytopenia, gelatinous marrow transformation
NeurologicBrain volume loss (partially reversible), cognitive impairment, peripheral neuropathy
DermatologicLanugo, dry skin, acrocyanosis, brittle nails, hair loss

Psychiatric Comorbidities

  • Depression, anxiety (OCD, social anxiety), substance use, personality disorders (avoidant, obsessive-compulsive), self-harm, suicidality.

Evidence-Based Treatment

  • Family-Based Treatment (FBT/Maudsley) – first-line for adolescents; parents manage refeeding.
  • Enhanced Cognitive Behavioral Therapy (CBT-E) – first-line for adults; addresses overvaluation of shape/weight, dietary restraint, body checking.
  • Specialist Supportive Clinical Management (SSCM) – alternative for adults.
  • Medical stabilization (inpatient) for severe malnutrition (BMI <15, HR <50, orthostasis, electrolyte derangements) – refeeding syndrome prevention (thiamine, slow caloric advance, phosphate monitoring).
  • Medications: No FDA-approved drug for AN core symptoms; olanzapine may aid weight gain/anxiety; SSRIs for comorbid depression/OCD (after weight restoration).

Prognosis

  • Recovery rates: ~50% full, ~30% partial, ~20% chronic.
  • Mortality: 5–10% per decade (highest of any psychiatric disorder).
  • Early intervention (<3 years duration) predicts better outcome.

Anorexia nervosa is a life-threatening illness requiring specialized, multidisciplinary care (medical, nutritional, psychiatric). Early referral to an eating disorder program saves lives.

Anorexia - Related Articles